Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study

• المؤلفون الرئيسيون: Calogera Butera (مؤلف), Ilaria Cetta (مؤلف), Roberta Messina (مؤلف), Laura Zanandrea (مؤلف), Roberto Santangelo (مؤلف), Bruno Colombo (مؤلف), Massimo Filippi (مؤلف), Ubaldo Del Carro (مؤلف)
• التنسيق: كتاب
• منشور في: SAGE Publishing, 2024-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Since the high burden of chronic migraine (CM), it is challenging to identify the best prevention treatment. Based on the preclinical evidence about the different therapeutic targets of onabotulinumtoxinA (BT-A), acting on C-fibers, and anti-CGRP monoclonal antibodies (mAbs), acting on Aδ-fibers, th...